The breast biopsy market has witnessed significant growth over the past few years, driven by the increasing incidence of breast cancer, advancements in biopsy techniques, and a growing demand for minimally invasive procedures. A breast biopsy is a procedure to remove a small sample of breast tissue for laboratory testing, primarily to detect breast cancer and other breast diseases. As of 2023, the market is valued at approximately USD 1.5 billion, with projections indicating an annual growth rate of 5% to 10% through 2029.
Moreover, the introduction of reimbursement policies for biopsy procedures in several countries is expected to propel the market further. Improved access to healthcare facilities also plays a significant role in the rising demand for breast biopsies.
This product will be delivered within 1-3 business days.
Market Size, Share & Trends Analysis Report
The breast biopsy market is categorized by product type, process, application, and end-use. Understanding each segment is crucial for market stakeholders.By Product Type
The breast biopsy market segments by products, including:- Core Needle Biopsy
- Stereotactic Biopsy
- Vacuum-Assisted Biopsy (VAB)
- Fine Needle Aspiration Biopsy (FNAB)
By Key Players
Major players in the breast biopsy market include:- Danaher Corporation
- BD
- Intact Medical Corporation
- Hologic
By Process
In terms of process, the breast biopsy market can be segmented into:- Surgical Biopsy
- Percutaneous Biopsy
By Application
The primary application of breast biopsy remains the diagnosis of breast cancer. However, other applications include:- Detection of Non-Cancerous Conditions
- Genetic Testing
By End-Use
The end-use categories for breast biopsies include:- Hospitals
- Diagnostic Centers
- Research and Academic Institutions
Market News on Policy and Companies
Recent policies aimed at improving breast cancer screening and diagnosis have contributed to market growth. Governments across various regions are increasing funding for cancer research, leading to innovations in biopsy technologies. Companies like Danaher Corporation and Hologic are at the forefront of introducing new technologies that comply with international standards, thus enhancing patient safety and efficacy of the procedures.Moreover, the introduction of reimbursement policies for biopsy procedures in several countries is expected to propel the market further. Improved access to healthcare facilities also plays a significant role in the rising demand for breast biopsies.
Segment Forecasts, 2024 - 2029
By maintaining a focus on technological advancements and continuous product development, the breast biopsy market is forecasted to experience substantial progress from 2024 to 2029. The market is expected to grow at a CAGR of 7%, resulting in a total value of over USD 2.1 billion by the end of the forecast period.Regional Analysis
Regionally, North America currently leads the breast biopsy market, accounting for approximately 40% of the market share in 2023. This is attributed to the high incidence of breast cancer, advanced healthcare infrastructure, and favorable reimbursement policies. The Asia-Pacific region, however, is expected to witness the highest growth rate, with an expected CAGR of 8% from 2024 onwards, driven by rapidly improving healthcare facilities and increasing awareness regarding breast cancer.Conclusion
The breast biopsy market is poised for growth, with key players continuously seeking innovative solutions to meet the evolving demands of clinicians and patients alike. As the global awareness of breast cancer escalates and as more efficient, accurate, and less invasive biopsy techniques are introduced, we can anticipate a robust market performance through to 2029.This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
Chapter 4 Market Landscape
Chapter 5 Market Trend Analysis
Chapter 6 Industry Chain Analysis
Chapter 7 Latest Market Dynamics
Chapter 8 Trading Analysis
Chapter 9 Historical and Forecast Breast Biopsy Market in North America (2020-2030)
Chapter 10 Historical and Forecast Breast Biopsy Market in South America (2020-2030)
Chapter 11 Historical and Forecast Breast Biopsy Market in Asia & Pacific (2020-2030)
Chapter 12 Historical and Forecast Breast Biopsy Market in Europe (2020-2030)
Chapter 13 Historical and Forecast Breast Biopsy Market in MEA (2020-2030)
Chapter 14 Summary For Global Breast Biopsy Market (2020-2025)
Chapter 15 Global Breast Biopsy Market Forecast (2025-2030)
Chapter 16 Analysis of Global Key Vendors
List of Tables and Figures
Companies Mentioned
- Danaher Corporation
- BD
- Intact Medical Corporation
- Hologic